Mary Adams

Lenalidomide Enhances Natural Killer Cell and Monocyte-Mediated Antibody-Dependent Cellular Cytotoxicity of Rituximab-Treated CD20+ Tumor Cells

Lei Wu, Mary Adams, Troy Carter et al. · Clinical Cancer Research · 2008 · 434 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Ronghui Lin, Sigmond G. Johnson, Peter J. Connolly et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 127 citations · Full text

Medicine, Medicinal Chemistry, Oncology +11

Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors

Ronghui Lin, George Chiu, Yang Yu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 121 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +12

2‐Chloro N⁶‐methyl‐(N)‐methanocarba‐2′‐deoxyadenosine‐3′,5′‐bisphosphate is a selective high affinity P2Y₁ receptor antagonist

José L. Boyer, Mary Adams, R. Gnana Ravi et al. · British Journal of Pharmacology · 2002 · 92 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

4-Amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitors

Guozhang Xu, M.C. Abad, Peter J. Connolly et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 89 citations · Full text

Medicine, Medicinal Chemistry, Oncology +11